Important safety information
NAD+ Nasal Spray
Common Side Effects
- Nasal dryness or irritation
- Sneezing or transient burning sensation
- Headache
- Mild dizziness
Nasal formulations may also cause flushing or nausea in sensitive individuals—report symptoms that escalate or interfere with daily activities.
More Serious Side Effects (less common)
- Allergic reaction (rash, swelling, shortness of breath)
- Dizziness or fainting
- Persistent fatigue or flu-like symptoms
- Flushing with rapid heartbeat
Stop treatment and seek medical care immediately if you experience signs of an allergic reaction or severe discomfort.
Warnings (serious risks)
- Do not exceed the dose prescribed by your provider.
- Use nasal spray formulations carefully to avoid irritation or overuse.
- Individuals with autoimmune, cardiovascular, or metabolic conditions should be monitored more closely.
Contraindications (not recommended for)
- Individuals with known hypersensitivity to NAD+ or formulation components
- People currently pregnant or breastfeeding
- Anyone with active infection, uncontrolled chronic illness, or ongoing cancer treatment without prior approval from their specialist
Drug interactions
- No widely reported drug interactions, but NAD+ may affect oxidative metabolism and mitochondrial function.
- Use caution if you are taking medications that impact energy metabolism, including insulin, metformin, or corticosteroids.
- Always disclose all prescription medications, supplements, and nasal or topical steroid therapies, and herbal products.
Pregnancy & Breastfeeding
NAD+ products are not recommended during pregnancy or while breastfeeding, as safety data in these populations is limited.
Storage
- Store at room temperature unless your pharmacy directs otherwise.
- Keep the cap tightly closed and avoid contamination of the nozzle.
- Keep out of reach of children.
Have Questions?
Consult your healthcare provider about spray technique, side effects, and whether nasal therapy is appropriate for you.
Disclaimer: Oat Meds helps connect patients with telehealth providers; medication is dispensed by licensed pharmacies. NAD+ nasal formulations obtained through the Oat Meds program may be compounded and prescribed off-label by licensed providers. These medications are not approved by the FDA. Statements above are for educational purposes and have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.